Standalone ~$7.3bn CapEx/financing need
Company: Core Scientific
The claim, verbatim
Core Scientific's standalone Colocation Pipeline plan needs about $7.3 billion of cumulative CapEx over eight years, with over 75% ($5.7 billion) in the first four years. Colocation Pipeline unlevered free cash flow stays negative until 2030.
Source (primary)
core-scientific 8-K exhibit (ef20056907_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-28)Live source ↗
Quote: “Core Scientific's Colocation Pipeline plan requires ~$7.3bn of cumulative CapEx spend over the next eight years, with over 75% ($5.7bn) required in the first four years (Colocation Pipeline UFCF remains negative until 2030E)”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The document states the ~$7.3bn eight-year CapEx need, the $5.7bn front-loaded portion, and negative Colocation Pipeline UFCF until 2030E.
Confirmed in the source:
- Core Scientific's standalone Colocation Pipeline plan requires about $7.3 billion of cumulative CapEx over the next eight years
- Over 75% of that CapEx ($5.7 billion) is required in the first four years
- Colocation Pipeline unlevered free cash flow remains negative until 2030
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000114036125037969/ef20056907_ex99-1.htm) in full (41,468 characters, retrieved September 28, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (ef20056907_ex99-1.htm)
Quote: “Core Scientific's Colocation Pipeline plan requires ~$7.3bn of cumulative CapEx spend over the next eight years, with over 75% ($5.7bn) required in the first four years (Colocation Pipeline UFCF remains negative until 2030E)”